Pit viper envenomation in dogs is managed with antivenom, IV fluid support, analgesia, and close monitoring for coagulopathy, cardiac arrhythmias, and acute kidney injury. Between 150,000 and 300,000 animals are bitten by pit vipers in the US annually, and overall mortality following crotalid envenomation ranges from 1% to 30%, with neurotoxic envenomation carrying mortality up to 17.6%.Journal of the…+1
Antivenom is the cornerstone of treatment and should be administered as early as possible. Indications for antivenom include rapid progression of swelling, severe coagulopathy, defibrination, thrombocytopenia, neuromuscular dysfunction, and shock.Journal of the… Antivenom is most effective when given immediately after envenomation, but benefit can still be realized long after envenomation if circulating venom remains present.Journal of the… In mild cases or those with only localized tissue effects, antivenom may not be necessary.Journal of the… The average case requires approximately 2 vials of polyvalent crotalid antivenom, though doses ranging from 1 to 20 vials have been reported.Toxicon Severe or persistent cases may require substantially more — up to 22 vials over 7 days has been documented.Journal of the… Antivenom infusion reactions are a recognized risk; preparation and administration should follow manufacturer instructions, including appropriate dilution in crystalloid fluid, use of a blood filter, and gradual rate escalation with continuous monitoring.Journal of the… High cumulative antivenom doses have been associated with both type I (anaphylaxis) and type III (serum sickness) hypersensitivity reactions.Journal of the…
Supportive care should begin immediately and includes IV isotonic crystalloid fluids, analgesia, and antiemetics. One documented protocol used hydromorphone 0.05 mg/kg IV q6h, maropitant 1 mg/kg IV q24h, and carprofen 4.4 mg/kg SC once.Journal of the… Potassium supplementation should be added to fluids when hypokalemia is present.Journal of the… Blood products are indicated for anemia and persistent bleeding.Toxicon
Coagulopathy monitoring is essential throughout hospitalization. Prothrombin time (PT), activated partial thromboplastin time (aPTT), and clotting times should be serially assessed.Journal of the… Conventional coagulation tests may be unreliable for early-stage detection of venom-induced consumptive coagulopathy; thromboelastography (TEG) can characterize both procoagulant and anticoagulant venom effects and may guide hemostatic resuscitation.Toxins Coagulation times that normalize during the first 3 days can revert to prolonged values with clinical deterioration — persistent or recurrent envenomation from delayed venom redistribution has been documented and requires additional antivenom doses.Toxicon Surgical debridement of necrotic tissue has been associated with recrudescence of systemic signs, potentially from release of deposited venom.Journal of the…
Cardiac monitoring is warranted, particularly when cardiac troponin I (cTnI) is elevated. Cardiac dysrhythmias occur in approximately 17% of envenomated dogs.Toxicon Data in dogs envenomated by Vipera berus show that 57% develop arrhythmias, all ventricular in origin, and 81% have elevated cTnI at one or more time points; elevated cTnI at 12, 24, and 36 hours post-bite is significantly associated with arrhythmia development.Journal of Vete… Prolonged electrocardiographic monitoring is advised when cTnI is elevated.Journal of Vete…
Acute kidney injury (AKI) develops in 29% of dogs treated with antivenom for pit viper envenomation and carries a significantly worse prognosis. Dogs that develop AKI have a survival-to-discharge rate of 31%, compared to 98% in dogs without AKI.Journal of Vete… AKI is associated with severity of shock at presentation, higher antivenom dose requirements, and need for packed red blood cell transfusion.Journal of Vete… Renal values should be monitored serially throughout hospitalization, particularly in hypotensive or tachycardic patients.Journal of Vete…
Neurotoxic envenomation — most notably with timber rattlesnake (Crotalus horridus) — can produce diffuse lower motor neuron dysfunction including ambulatory tetraparesis to tetraplegia, postural reaction deficits, depressed spinal reflexes, and muscle fasciculations.Journal of the… Intravenous calcium administration may decrease clinical signs of neurotoxic envenomation.Journal of the… One vial of antivenin (Crotalidae Polyvalent) resulted in neurologic resolution within 48 hours in a documented case.Journal of the…
Bite location influences prognosis — mortality is higher for bites to the thorax or abdomen than to the head or extremities, and approximately 80% of bites in one case series involved the head region.Toxicon+1
Owner expectations at discharge: approximately 78% of dogs return to normal behavior within 3 to 5 days following envenomation, and 45% are perceived by owners to have returned to normal immediately with no observed delay.American Journa… Lethargy is reported by approximately 68.6% of owners post-discharge and may reflect pain, residual swelling, or analgesic effects; veterinary reevaluation is warranted if lethargy persists beyond 3 to 5 days.American Journa…
A rare but serious late complication is bacterial endocarditis, documented in a dog that developed fever, lameness, inappetence, and a new heart murmur 2 weeks after pit viper envenomation; postmortem confirmed Enterobacter cloacae and Enterococcus faecium endocarditis, both organisms reported in the oral cavity of pit vipers.Veterinary Reco… Dogs that deteriorate or develop new clinical signs weeks after envenomation should be evaluated for this complication.Veterinary Reco…
Regarding rattlesnake toxoid vaccination: no published data document efficacy of the western diamondback rattlesnake (Crotalus atrox) venom toxoid in dogs, cross-protection against other pit vipers is unsupported by peer-reviewed data, and anaphylaxis in previously vaccinated then envenomated dogs has been reported; polyvalent antivenom remains the recommended treatment for suspected rattlesnake bite.AAHA Clinical G…
| Parameter | Value | Source |
|---|---|---|
| Overall crotalid mortality | 1–30% | Journal of the… |
| Neurotoxic envenomation mortality | Up to 17.6% | Journal of the… |
| Average antivenom dose | ~2 vials (range 1–20) | Toxicon |
| AKI incidence (antivenom-treated dogs) | 29% | Journal of Vete… |
| Survival to discharge, AKI group | 31% | Journal of Vete… |
| Survival to discharge, non-AKI group | 98% | Journal of Vete… |
| Cardiac dysrhythmia incidence | 17% | Toxicon |
| Coagulopathy incidence | 21% | Toxicon |
| Return to normal behavior within 3–5 days | ~78% | American Journa… |
| Head/neck bite location | ~80% of cases | Toxicon |
Would you like guidance on managing persistent or recurrent envenomation when clinical signs relapse after initial antivenom treatment?
